John L. Hungerford - Concepedia

Author

John L. Hungerford

Also Known As

J Hungerford, J L HUNGERFORD, J L Hungerford, J. HUNGERFORD, J. Hungerford, J. L Hungerford, J. L. HUNGERFORD, J. L. Hungerford, J.L. Hungerford, JOHN L. HUNGERFORD

152

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

University College London St Bartholomew's Hospital Moorfields Eye Hospital Moorfields Eye Hospital NHS Foundation Trust Institute of Ophthalmology

About

John L. Hungerford is an author at University College London specializing in medicine, ophthalmology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	56	3K
2	Health Sciences	7	7	407
3	Cell Biology	1	1	50
4	Endocrinology	1	1	44
5	Gastroenterology	1	1	20

John L. Hungerford

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
OCULAR TOXICITY OF HIGH-DOSE INTRAVENOUS DESFERRIOXAMINE SallyC. Davies, John L. Hungerford, G. B. Arden, The Lancet Ocular DiseaseOphthalmologyExperimental OphthalmologyMedicineToxicology	1983	270
Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Dion Paridaens, A C McCartney, John L. Hungerford British Journal of Ophthalmology Prognostic FactorsSurgical OncologyYear Survival RateTumoral PathologyConjunctival Malignant Melanoma	1994	244
Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma Matthew W. Wilson, John L. Hungerford Ophthalmology Radiation MedicineRadiation TherapyMedicineEpiscleral PlaqueChoroidal Melanoma	1999	188
Topical Mitomycin C for the Treatment of Conjunctival and Corneal Epithelial Dysplasia and Neoplasia Matthew W. Wilson, John L. Hungerford, SHEENA M. GEORGE, American Journal of Ophthalmology Corneal Epithelial DysplasiaTopical Mitomycin COphthalmologyCorneal DystrophyPathology	1997	164
Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Dion Paridaens, A C McCartney, John L. Hungerford British Journal of Ophthalmology Neuro-oncologySurgical OncologyTumoral PathologyOphthalmologyOculoplastics	1994	154
Microvessel count predicts survival in uveal melanoma. A. Foss, Robert Alexander, L W Jefferies, PubMed Microvessel Count PredictsMicrovessel DensitySkin CancerMedicineMelanoma	1996	143
Choroidal Hemangiomas Steven A. Madreperla, John L. Hungerford, P.N. Plowman, Ophthalmology	1997	142
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Helen S. L. Chan, George Deboer, Jake J. Thiessen, PubMed Ocular DiseaseVitreous BodyBilateral Retinoblastoma PatientsOphthalmologyExperimental Ophthalmology	1996	139
Delay in diagnosis of retinoblastoma: risk factors and treatment outcome Anthony Goddard, J E Kingston, John L. Hungerford British Journal of Ophthalmology	1999	137
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma J. Chana, George D. Wilson, Ian A. Cree, British Journal of Ophthalmology	1999	99

Page 1